Stay updated on CDX-1401+INCB024360 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the CDX-1401+INCB024360 in Ovarian Cancer Clinical Trial page.

Latest updates to the CDX-1401+INCB024360 in Ovarian Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to reflect a new pharmacological study involving a combination of treatments for ovarian, fallopian tube, and primary peritoneal carcinoma, with significant details about the study's collaborators and identifiers added. The previous study description has been removed, indicating a shift in focus to a new trial version.SummaryDifference45%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to CDX-1401+INCB024360 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-1401+INCB024360 in Ovarian Cancer Clinical Trial page.